by H.S. Ayoub
BioHealth Investor.com
Biotechnology
GENETIC TECH SPON [GENE] +21.89%
CURAGEN CORP [CRGN] +8.58%
CYTORI THERAPEUTICS [CYTX] +7.64%
BIOSANTE PHARMA INC [BPA] +7.41%
CHELSEA THERAPEUTICS [CHTP] +7.12%
Diagnostic Substances
HEALTHCARE TECH LTD [HCTL] +9.57%
INTERLEUKIN GENETICS [ILI] +6.12%
SCOLR PHARMA INC [DDD] +5.82%
RG GLBL LIFESTYLS [RGBL.OB] +4.96%
GENE LOGIC INC [GLGC] +4.52%
Drug Delivery
BIOPROGRESS PLC [BPRG] +7.55%
FLAMEL TECH SA ADR [FLML] +5.15%
ELAN CP PLC ADR [ELN] +2.47%
DELCATH SYSTEMS INC [DCTH] +2.08%
NEKTAR THERAPEUTIC [NKTR] +1.23%
Drug Manufacturers
INTERPHARM HLDGS INC [IPA] +14.65%
AVI BIOPHARMA INC [AVII] +9.75%
SIMCERE PHARMA ADS [SCR] +5.35%
ANGIOTECH PHARMA I [ANPI] +5.03%
TELIK INC [TELK] +4.94%
Drug Related Products
MANNATECH INC [MTEX] +8.80%
XELR8 HOLDINGS, INC [BZI] +5.66%
SALIX PHARM DEL [SLXP] +3.77%
N B T Y INC [NTY] +2.46%
PRESTIGE BRAND HLGS [PBH] +1.47%
Generic Drugs
CATALYST PHARMACEUTI [CPRX] +3.90%
HI-TECH PHARMACAL [HITK] +1.29%
CARACO PHARMA LABS [CPD] +0.55%
MYLAN LABS INC [MYL] +0.45%
BARR PHARMA INC [BRL] +0.12%
Medical Appliances & Equipment
CRYOLIFE INC [CRY] +16.08%
DIGIRAD CORPORATION [DRAD] +4.57%
CRITICARE SYS INC [CMD] +3.37%
CYNOSURE, INC. [CYNO] +2.97%
CHOLESTECH CORP [CTEC] +2.76%
Medical Instruments & Supplies
ANGEION CORP [ANGN] +13.56%
CRYOCOR, INC. [CRYO] +11.38%
ANTARES PHARMA INC [AIS] +11.04%
VYTERIS HOLDINGS NV [VYHN.OB] +9.33%
LEMAITRE VASCULAR [LMAT] +6.37%
Medical Laboratories & Research
LABORATORY CORP NEW [LH] +1.14%
SPHERIX INC [SPEX] +1.08%
BIO-REFERENCE LAB [BRLI] +0.94%
ERESEARCHTECHNOLOG [ERES] +0.85%
MEDTOX SCIENTFIC INC [MTOX] +0.83%
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.